Gastroenterology
1 drug is in development for Primary Sclerosing Cholangitis.
- Companies
- 1
- Clinical trials
- 11
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Primary Sclerosing Cholangitis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| aldafermin | NGM BIOPHARMACEUTICALS INC (NGM) |
About this indication
Primary Sclerosing Cholangitis context
Gastroenterology·MeSH: Cholangitis, Sclerosing (D015209)
Frequently asked questions
How many drugs are in development for Primary Sclerosing Cholangitis?
BioSniper tracks 1 drug in development for Primary Sclerosing Cholangitis across 1 company.
How many clinical trials target Primary Sclerosing Cholangitis?
There are 11 clinical trials targeting Primary Sclerosing Cholangitis tracked by BioSniper.